1
|
Sabblah GT, Taxis K, Duwiejua M, Seaneke SK, van Puijenbroek E, van Hunsel F. Achieving patient engagement in pharmacovigilance: from high-income countries to lower and -middle-income countries with focus on Africa. Expert Opin Drug Saf 2024. [PMID: 39400306 DOI: 10.1080/14740338.2024.2416916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2024] [Revised: 09/04/2024] [Accepted: 10/10/2024] [Indexed: 10/15/2024]
Abstract
INTRODUCTION Patient engagement in pharmacovigilance (PEP) has been shown to improve information on adverse drug reactions (ADRs), which may not be found in reports from healthcare professionals. This review shows that there is paucity of information on PEP in lower-middle-income countries (LMICs), particularly Africa. It provides insights into PEP in high-income countries (HICs) compared with Africa to help identify the disparities and system challenges in Africa. AREAS COVERED We discussed the impact of PEP in HICs in comparison with Africa and incorporated two case studies: PEP in Ghana and medication error reporting in Africa using a scoping review. Recommendations were made to improve medication safety in Africa based on the identified disparities and system challenges. EXPERT OPINION PEP is at an early stage in LMICs, particularly in Africa, with limited information available regarding patients' contributions to the safety of medicines. There should be further research into patients' roles in pharmacovigilance accompanied by advocacy efforts with policymakers, the development of sustainable funding strategies, benchmarking against experienced pharmacovigilance centers, and the use of technology to improve patient reporting.
Collapse
Affiliation(s)
- George Tsey Sabblah
- Food and Drugs Authority, Accra, Ghana
- PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, the Netherlands
| | - Katja Taxis
- PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, the Netherlands
| | - Mahama Duwiejua
- School of Pharmacy, College of Health Sciences, University of Ghana, Legon, Ghana
| | | | - Eugène van Puijenbroek
- PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, the Netherlands
- Netherlands Pharmacovigilance Centre Lareb, 's-Herteogenbosch, the Netherlands
| | - Florence van Hunsel
- PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, the Netherlands
- Netherlands Pharmacovigilance Centre Lareb, 's-Herteogenbosch, the Netherlands
| |
Collapse
|
2
|
Seselja Perisin A, Bukic J, Rusic D, Leskur D, Bozic J, Mihanovic A, Vilovic M, Cohadzic T, Modun D. Teaching Pharmacovigilance to Healthcare Students: Identifying Gaps and Opportunities for Improvement. PHARMACY 2021; 9:147. [PMID: 34449747 PMCID: PMC8396247 DOI: 10.3390/pharmacy9030147] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 08/21/2021] [Accepted: 08/24/2021] [Indexed: 12/03/2022] Open
Abstract
The literature indicates that the limited pharmacovigilance knowledge demonstrated by healthcare professionals is the main reason for the underreporting of adverse drug reactions. Therefore, the main objective of this study was to investigate pharmacy, dental and medical students' knowledge and attitudes to pharmacovigilance and pharmacovigilance education. The cross-sectional questionnaire study was conducted at the University of Split School of Medicine in November 2020. In total, 350 students participated in the study. The results have shown that pharmacy students showed a significantly higher knowledge score compared to dental and medical students (P < 0.001). In total 92.2% of pharmacy, 21.8% of dental and 70.8% of medical students had knowledge of patients' involvement in adverse drug reactions, reporting (P < 0.001). Interestingly, only 44.3% of all students knew that adverse drug reactions could be reported using a mobile application. Moreover, significantly more pharmacy students (74.4%) were aware of the adverse drug reactions monitoring center in Croatia, with 47.5% of dental and 39.2% of medical students correctly identifying it (P < 0.001). The results showed that most students felt that pharmacovigilance was not adequately covered in curricula; therefore, there is a great need to increase the knowledge and awareness of pharmacovigilance among students aspiring to become future healthcare professionals, and improve their reporting practice in clinical future.
Collapse
Affiliation(s)
- Ana Seselja Perisin
- Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (A.S.P.); (J.B.); (D.R.); (D.L.); (A.M.); (T.C.)
| | - Josipa Bukic
- Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (A.S.P.); (J.B.); (D.R.); (D.L.); (A.M.); (T.C.)
| | - Doris Rusic
- Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (A.S.P.); (J.B.); (D.R.); (D.L.); (A.M.); (T.C.)
| | - Dario Leskur
- Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (A.S.P.); (J.B.); (D.R.); (D.L.); (A.M.); (T.C.)
| | - Josko Bozic
- Department of Pathophysiology, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (J.B.); (M.V.)
| | - Ante Mihanovic
- Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (A.S.P.); (J.B.); (D.R.); (D.L.); (A.M.); (T.C.)
- Split-Dalmatia County Pharmacy, Kneza Ljudevita Posavskog 12 b, 21 000 Split, Croatia
| | - Marino Vilovic
- Department of Pathophysiology, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (J.B.); (M.V.)
| | - Tin Cohadzic
- Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (A.S.P.); (J.B.); (D.R.); (D.L.); (A.M.); (T.C.)
| | - Darko Modun
- Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia; (A.S.P.); (J.B.); (D.R.); (D.L.); (A.M.); (T.C.)
| |
Collapse
|